Target intelligence / Profile preview

UBE2E2 divergent transcript (UBE2E2-DT)

Target
UBE2E2-DT
Molecular classification
long non-coding RNA (lncRNA)
01

Overview

UBE2E2 divergent transcript (UBE2E2-DT) is a human long non-coding RNA (lncRNA) gene, and is affiliated with the lncRNA molecular class. It is also known as UBE2E2-AS1 and UBE2E2 antisense RNA 1 (head to head)[3]. Unlike closely related protein-coding genes such as UBE2E2, which encodes an E2 ubiquitin-conjugating enzyme, UBE2E2-DT produces a non-coding RNA molecule whose precise biological and pathological roles are not currently documented in major genetic or biomedical databases. It is classified only as an lncRNA gene, and there is no evidence of it serving as a druggable therapeutic target, disease biomarker, nor having known drug interactions or therapy-related safety concerns[3]. The gene is cataloged in the HGNC (44512), NCBI Gene (100505877), and Ensembl (ENSG00000233153) databases, highlighting its confirmed identity as a human lncRNA[3]. In summary, UBE2E2-DT is an lncRNA with no established disease roles, therapeutic targeting, or documented molecular functions, and should not be classified as a conventional drug target.

Other names
UBE2E2-AS1UBE2E2 antisense RNA 1 (head to head)UBE2E2-DT

Beyond the preview

Go deeper on UBE2E2 divergent transcript (UBE2E2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2E2 divergent transcript (UBE2E2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call